首页>
外国专利>
SINGLE-LAYER ORAL DOSE OF NEURO-ATTENUATING KETAMINE
SINGLE-LAYER ORAL DOSE OF NEURO-ATTENUATING KETAMINE
展开▼
机译:单层口服剂量神经衰减氯胺酮
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is directed to oral neuro-attenuating ketamine (NAKET) tablet formulations, and methods of administration, which ensure the steady release of a therapeutically effective concentration of ketamine from an oral tablet without neurologically toxic spikes in ketamine concentration. In particular, the present invention provides single layer oral tablet formulation of NAKET. In a specific embodiment, the NAKET tablet formulation, and methods of administration provide steady administration of NAKET to a subject for 24 hours or greater, for example, up to 36 hours, after a single administration event.
展开▼